Skip to content

Optimisation Strategy for Emergency Tracheal Intubation

Effectiveness of an Optimisation Strategy for Emergency Tracheal Intubation on Postintubation Morbidity: A Cluster Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05539391
Acronym
OSETIM
Enrollment
1500
Registered
2022-09-14
Start date
2023-01-14
Completion date
2026-09-30
Last updated
2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergencies, Out-of-hospital Setting, Tracheal Intubation

Keywords

Out-of-hospital, Intubation, Complications, Vital distress, Rapid sequence intubation, Rocuronium, Gum Elastic Bougie

Brief summary

This study has to objective to assess, in adults' patients needing tracheal intubation because of vital distress, the effect of a combined strategy to reduce intubation-related morbidity. This strategy will associate systematic use of rocuronium as paralyzing agent to facilitate tracheal intubation, bag face-mask ventilation before intubation and Gum Elastic Bougie (GEB) use.

Detailed description

Several studies have reported positive impact of some interventions on the tracheal intubation-related complications incidence. Providing bag face-mask ventilation between medication administration and initiation of laryngoscopy significantly reduced the number of peri intubation hypoxemia episodes. The use of a non-depolarizing (rocuronium) paralytic agent instead of succinylcholine is associated with less post-intubation complications occurrence. Finally, use of a tracheal tube introducer (GEB) as an aid for intubation in emergency patients with at least one prognostic factor of difficult laryngoscopy has been shown to facilitate intubation. Assessment of a strategy combining these three interventions to reduce intubation related morbidity in emergency situations has never been assessed. It is expected that the combination of these interventions will drastically reduce the morbidity associated with emergency intubation. The strategy assessed will associate rocuronium use as paralyzing agent to facilitate intubation, bag mask ventilation before intubation and GEB use at first intubation attempt in all patients. The emergency physician in charge of the patients will record out-of hospital outcomes immediately after the out-of-hospital period. Intra-hospital data will be retrieved from the patient's medical record on the 28th day after inclusion.

Interventions

PROCEDURERapid sequence intubation (RSI) : Rocuronium /Bag-mask ventilation /GEB

Rapid sequence intubation (RSI) will be performed with use of rocuronium as paralytic agent (1.2 mg/ kg). Bag-mask ventilation between induction and laryngoscopy will be performed. The GEB will be systematically used at the first attempt to facilitate intubation.

OTHERData patient

Medical History and characteristic of patient

OTHERPhysical examination

Arterial pressure, arterial oxygen saturation, heart rate

PROCEDURERapid sequence intubation (RSI) : Recommendations for emergency intubation

Rapid sequence intubation (RSI) using succinylcholine as a paralytic agent (1 mg/kg), no systematic bag-mask ventilation between induction and laryngoscopy, use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient adult (≥ 18 years) presenting with vital distress requiring emergency tracheal intubation as assessed by the emergency physician in the out-of-hospital setting. * Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included.

Exclusion criteria

* Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist). * Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis). * Patient that are not members of a medical aid scheme (beneficiary or main member). * Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.

Design outcomes

Primary

MeasureTime frameDescription
Severe intubation-related complications occurring during the first hour after intubationDay 0Proportion of patients with severe intubation-related complications occurring during the first hour after intubation The severe intubation-related complications are: * Cardiac arrest. * At least one arterial hypotension episode defined by systolic blood pressure\<90 mmHg. * At least one hypoxemia episode defined by an occurrence of a new episode of oxygen. * Saturation \< 90%. * Severe cardiac arrhythmia: ventricular tachycardia. * Pulmonary aspiration, reported by the physician. * Esophageal intubation. * Unintentional extubation. Severe intubation-related complications will be recorded by the emergency physician in charge of the patient.

Secondary

MeasureTime frameDescription
Difficulty of the intubation process - Intubation conditions assessed by the CopenhagenDay 0Intubation conditions assessed by the Copenhagen score - The value is clinically not acceptable and clinical acceptable
Difficulty of the intubation process - Alternative techniques.Day 0Proportion of patients intubated by alternative techniques.
Difficulty of the intubation process - Intubation attemptsDay 0Mean number of intubation attempts
Difficulty of the intubation process - Intubation failures under direct laryngoscopy.Day 0Mean number of intubation failures under direct laryngoscopy.
Difficulty of the intubation process - Intubation DifficultyDay 0Intubation Difficulty Score (IDS). minimum values is 0 and the maximum values is dependent on the added elements.
Out-of hospital care - sedative drugsDay 0Mean total amount of sedative drugs used after intubation
Out-of hospital care - vasopressorsDay 0Mean total amount of vasopressors used after intubation
Out-of hospital care : MortalityDay 0Out-of-hospital mortality.
MortalityDay 28Vital status
Out-of hospital care -Time of out-of-hospital careDay 0Mean time of out-of-hospital care (in minutes)

Countries

France

Contacts

Primary ContactXavier COMBES, Pr
xavier.combes@chu-bordeaux.fr05 56 79 49 47

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026